| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033661 |
| Receipt No. | R000038376 |
| Scientific Title | Efficacy study of cataract surgery using femtosecond laser |
| Date of disclosure of the study information | 2018/08/07 |
| Last modified on | 2021/02/08 (Ver. 7) |
| Basic information | ||
| Public title | Efficacy study of cataract surgery using femtosecond laser | |
| Acronym | Study of FLACS efficacy | |
| Scientific Title | Efficacy study of cataract surgery using femtosecond laser | |
| Scientific Title:Acronym | Study of FLACS efficacy | |
| Region |
|
|
| Condition | ||
| Condition | Cataract | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare postoperative progress of FLACS by multiple surgeons |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Complications, visual acuity and intraocular pressue one day, 5 days, 1 month, 3 months, 6 months after the surgery, corneal endothelial cell density, flare value, corneal shape will be studied and slit lamp microscopy will be conducted. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 3 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Femtosecond laser cataract surgery device will be used during cataract surgery (operator A) | ||
| Interventions/Control_2 | Femtosecond laser cataract surgery device will be used during cataract surgery (operator B) | ||
| Interventions/Control_3 | Femtosecond laser cataract surgery device will be used during cataract surgery (operator C) | ||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with visual function disorder due to cataract
Emery-Little classification of grade I to IV cataract |
|||
| Key exclusion criteria | Patient with Grade V cataract of Emery-Little classification, mature cataract, hypermature cataract, corneal disease, corneal opacity, macular disease or advanced glaucoma patient who is likely to have lower visual acuity after the surgery, uncontrolled diabetes, patient who cannot fix vision intraoperatively, who cannot rest, open eyelid, dilate pupil (exfoliation syndrome, etc.) , and patient with history of trauma. | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Chukyo Eye Clinic | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 4560032 | ||||||
| Address | 12-22 Sanbonmatsu-cho Atsuta-ku, Nagoya, Aichi | ||||||
| TEL | 052-883-1543 | ||||||
| ichikawa@chukyogroup.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Chukyo Eye Clinic | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 4560032 | ||||||
| Address | 12-22 Sanbonmatsu-cho Atsuta-ku, Nagoya, Aichi | ||||||
| TEL | 052-883-1543 | ||||||
| Homepage URL | |||||||
| takagi@chukyogroup.jp | |||||||
| Sponsor | |
| Institute | Chukyo Eye Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB of Chukyo Medical Co.,Ltd |
| Address | 12-23 Sanbonmatsu-cho, Atsuta-ku, Nagoya-city, Aichi |
| Tel | 052-884-7976 |
| irb@chukyomedical.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 100 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038376 |